ALLMedicine™ Arrhythmogenic Right Ventricular Dysplasia Center

Jul 6th, 2022 - Arrhythmogenic right ventricular dysplasia (ARVD) is a rare cardiomyopathy characterized by the progressive replacement of cardiomyocytes by fatty and fibrous tissue in the right ventricle (RV). These infiltrations lead to cardiac electrical insta...

Apr 21st, 2022 - Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is characterized by ventricular arrhythmias (VAs) and sudden cardiac death (SCD). We aimed to develop a model for individualized prediction of incident VA/SCD in ARVC patients. Five ...

Dec 30th, 2021 - Advances in paediatric cardiology has improved the prognosis of children with inherited cardiac disorders. However, quality of life and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardio...

May 21st, 2021 - Left ventricular (LV) fibrofatty infiltration in arrhythmogenic right ventricular (RV) dysplasia/cardiomyopathy (ARVD/C) has been reported, however, detailed cardiovascular magnetic resonance (CMR) characteristics and association with outcomes are...

Apr 17th, 2021 - Hepatitis C virus (HCV) infection is an important cause of a variety of otherwise unexplained heart diseases and myocardial injury. A high prevalence of HCV infection has been noted in patients with hypertrophic cardiomyopathy, dilated cardiomyopa...

Mar 4th, 2009 - Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/ca...

Jul 6th, 2022 - Arrhythmogenic right ventricular dysplasia (ARVD) is a rare cardiomyopathy characterized by the progressive replacement of cardiomyocytes by fatty and fibrous tissue in the right ventricle (RV). These infiltrations lead to cardiac electrical insta...

Dec 30th, 2021 - Advances in paediatric cardiology has improved the prognosis of children with inherited cardiac disorders. However, quality of life and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardio...

Nov 25th, 2013 - Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/ARVC), is an inherited myocardial disease that predominantly affects the right ventricle (RV) and the estimated prevalence in the general population ranges from 1 to 5 in 1000. It is ...

Jan 13th, 2010 - Molecular genetic screening in patients with: supraventricular ventricular arrhythmia syncopes of unknown origin and/or suspicion of an arrhythmogenic origin family members of patients with sudden cardiac death and aborted sudden cardiac death Exa...

Mar 4th, 2008 - Arrhythmogenic right ventricular cardiomyopathy (ARVC) formerly referred to as arrhythmogenic right ventricular dysplasia (ARVD) is a familial hetergenous clinical and molecular disease characterized by dilatation and dysfunction of the right vent...

Nov 17th, 2014 - Brugada: Multifaceted and Misunderstood Rajiv Gulati, MD, PhD: I am Rajiv Gulati from the Division of Cardiovascular Diseases Mayo Clinic, Rochester, Minnesota. I am joined today by my colleague, Dr Suraj Kapa, who is also a cardiologist, and spec...

Apr 3rd, 2014 - WASHINGTON, DC — In the end, it really wasn't much of a debate at all. Two experts, citing similar research, made the case that most athletes with heart problems requiring an implantable cardioverter defibrillator (ICD) should be allowed to partic...

Jun 26th, 2013 - There's a lot controversy surrounding the relationship between endurance exercise and heart disease. Smart people debate the issue of causality, the dosage of exercise needed to provoke disease, and many other confounding factors. But one thing we...

Sep 7th, 2012 - This feature requires the newest version of Flash. You can download it here. Dr Samuel Asirvatham joins the show to discuss arrhythmogenic right ventricular dysplasia (ARVD), the second most common cause of death in young athletes after hypertroph...

May 11th, 2012 - BOSTON – Athletes with implantable cardioverter defibrillators may not need to be sidelined when the action gets fast and furious, say investigators in a multicenter study presented at the annual meeting of the Heart Rhythm Society. Although inter.